Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combination Chemotherapy in High-Risk Childhood Acute Lymphoblastic Leukemia
NCT00002812Phase 3Completed
- Sponsor
- Children's Oncology Group
- Start
- Sep 1996
- Primary completion
- Mar 2006
- Modality
- Monoclonal Antibodies, Orthosteric Ligands, Replacement Enzymes
- Countries
- 3
01
Overview
A Phase 3 trial of vincristine sulfate liposome injection, daunorubicin, prednisone, cytarabine, asparaginase escherichia coli in acute lymphoblastic leukemia (ALL), sponsored by Children's Oncology Group. Started Sep 1996; status: completed.
02
Drugs
vincristine sulfate liposome injectiondaunorubicinprednisonecytarabineasparaginase escherichia coli
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00002812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002812.